Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Materials and methods for treatment of hemoglobinopathies

Materials and methods for treatment of hemoglobinopathies

US Patent 12134767 · Granted Nov 5, 2024

Estimated economic value: $712,433,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Scarless genome editing through two-step homology directed repair2025
Materials and methods for treatment of human genetic diseases including hemoglob2024
Materials and methods for treatment of hemoglobinopathies2024
Genome editing of graft-derived T-cells for post-transplant immunotherapy2024
Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated e2023
CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous re2023
Scarless genome editing through two-step homology directed repair2023
Pharmaceutical compositions comprising gene-corrected primary cells2023
Chemically modified guide RNAS for CRISPR/Cas-mediated gene regulation2022
Nuclease-mediated genome editing of primary cells2022
Chemically modified guide RNAs for CRISPR/CAS-mediated gene regulation2022
Nuclease-mediated genome editing of primary cells and enrichment thereof2021